Abstract
Objective: This study conducted in Sergipe aimed to investigate the impacts of the COVID-19 pandemic on the diagnosis and treatment of cancer patients. Methods: A quantitative cross-sectional study of an observational-analytical nature was carried out, involving a sample of the oncology population exposed to the public emergency of COVID-19. Data collection initially took place through an electronic questionnaire disseminated by WhatsApp, later carried out in person in the waiting rooms of two public hospitals in Sergipe, due to low electronic adherence. The questionnaire included 22 objective multiple-choice questions about oncological disease and COVID-19. Results: A total of 103 individuals participated in the study, with a mean age of 56.2 years. Men were older than women (p=0.049). Breast cancer was the most prevalent, followed by head and neck cancer. The reported feelings included sadness, fear, anxiety and nervousness when they received the cancer diagnosis. Positive testing for COVID-19 was reported by 42.7% of the participants. Conclusion: No significant impacts were observed on the diagnosis and treatment of neoplasms during the COVID-19 pandemic, despite changes in health services. Participants reported no absences or interruptions in cancer treatment, maintaining medical appointments and performing exams as needed.
DOI:https://doi.org/10.56238/sevened2024.030-010